QHM-2025-8082 Brampton Pharmacy

The recent procurement process involves NHS North East and North Cumbria Integrated Care Board, seeking to award a contract titled "QHM-2025-8082 Brampton Pharmacy" within the pharmacy services sector. This contract pertains to services in the UK region identified as UKC, specifically leveraging a direct award process under the Health Care Services (Provider Selection Regime) Regulations 2023. The contract is set to commence on 1st April 2025 and conclude on 31st March 2026, with an activity-based value and no guaranteed contract amount.

The procurement method was limited, executed without prior publication of a call for competition. The process has already advanced to the stage where the contract is active, as confirmed on 16th July 2025 following the conclusion of a standstill period for provider representation which ended on 13th October 2025. This tender presents growth opportunities for businesses specialising in pharmacy services, particularly those with existing relationships or contracts with the NHS, as the procurement has utilised a direct award mechanism due to a past satisfactory provider performance.

Businesses capable of demonstrating similar service delivery effectiveness would find this tender aligned with their operational strengths. The integration of a contract in this sector can enhance a company’s portfolio through alignment with public health procurement objectives, especially for large-scale service providers. Stakeholders in the pharmacy services industry, including established providers and those capable of meeting stringent NHS standards, would be well-suited to engage with this contracting process.